EGFR expression has also been studied using panitumumab labeled with [89Zr]Zr-Panitumumab is a completely humanized mAb that binds to the EGFR, and it is FDA (Food and Drug Administration)-approved for use in receptor expressing colorectal cancers without KRAS mutations [30]. The gene discussed is EGFR; the disease is colorectal cancer.